Diabetes affects over 500 million people worldwide, and managing blood glucose levels typically requires medication. The landscape of diabetes treatment has expanded dramatically in recent years, with new drug classes offering benefits beyond blood sugar control. Understanding how each medication works helps patients take an active role in their treatment.

Metformin remains the gold standard for type 2 diabetes. It works primarily by reducing glucose production in the liver and improving insulin sensitivity in muscle tissue. It does not cause hypoglycemia when used alone, does not cause weight gain (and may even promote modest weight loss), and is extremely affordable. The most common side effects are gastrointestinal — nausea, diarrhea, and abdominal discomfort — which can be minimized by starting at a low dose, taking it with food, and using the extended-release formulation.

Sulfonylureas (glimepiride, gliclazide, glipizide) stimulate the pancreas to release more insulin. They are effective and inexpensive but carry a risk of hypoglycemia (low blood sugar) and weight gain. Meglitinides (repaglinide, nateglinide) work similarly but act faster and shorter, taken before meals. Both classes are less popular now due to newer options with better safety profiles.

GLP-1 receptor agonists (semaglutide/Ozempic, liraglutide/Victoza, dulaglutide/Trulicity) have transformed diabetes management. They mimic the incretin hormone GLP-1, which:

- Stimulates insulin release only when blood sugar is high (reducing hypoglycemia risk)

- Slows gastric emptying (increasing satiety)

- Promotes significant weight loss (5-15% of body weight)

- Shows cardiovascular and renal protective effects

They are administered as weekly or daily injections, though oral semaglutide (Rybelsus) is also available. Common side effects include nausea and gastrointestinal symptoms, usually improving over weeks.

SGLT2 inhibitors (empagliflozin/Jardiance, dapagliflozin/Forxiga, canagliflozin/Invokana) work by blocking glucose reabsorption in the kidneys, causing excess glucose to be excreted in urine. Beyond blood sugar control, they provide proven cardiovascular and kidney protection and promote weight loss. Important considerations include increased risk of urinary tract infections, genital yeast infections, and rare diabetic ketoacidosis. Adequate hydration is essential.

Insulin is essential for all type 1 diabetics and many type 2 diabetics when oral medications alone are insufficient. Modern insulin types include:

- Rapid-acting (lispro, aspart, glulisine) — onset 15 min, used before meals

- Short-acting (regular insulin) — onset 30 min

- Intermediate-acting (NPH) — lasts 12-16 hours

- Long-acting (glargine/Lantus, detemir/Levemir) — provides 24-hour basal coverage

- Ultra-long-acting (degludec/Tresiba) — lasts 42+ hours

Proper insulin storage (refrigerated before opening, room temperature for 28 days after), injection site rotation, and recognizing signs of hypoglycemia are critical for safe use.

Diabetes management is not one-size-fits-all. Your treatment plan should be regularly reviewed and adjusted based on:

- HbA1c levels (target usually below 7% or 53 mmol/mol)

- Blood glucose patterns from self-monitoring or CGM

- Side effects and tolerability

- Cardiovascular and kidney risk factors

- Cost and access considerations

Never adjust or stop diabetes medication without consulting your healthcare provider. PillsCard can help you track your medications and set reminders for doses and refills.